Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical management of domestic GnRH antagonists in assisted reproductive technology
ChiCTR2300072430Phase 4Recruiting
- Sponsor
- Reproductive Hospital affiliated with Shandong University
- Start
- Jun 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ganirelix in infertility, sponsored by Reproductive Hospital affiliated with Shandong University. Primary endpoint: Ongoing pregnancy rate. Started Jun 2023; status: recruiting.
02
Drugs
ganirelix
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2300072430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072430.